Introduction
Four decades ago, pioneering observations of endocrine disruption reported vaginal adenocarcinoma in adult daughters of women treated with diethylstilbestrol (DES) during pregnancy [1] . Since then, evidence has accumulated that numerous endocrine-disrupting compounds (EDCs) could cause disorders not only of the adult reproductive system but also of other aspects of homeostasis at different periods of life [2 ] . Here, our aim is to review some general issues about EDCs, to focus on possible EDC effects on growth and development and to provide the pediatrician with some recommendations in order to minimize EDC exposure at critical periods of life.
Definition of endocrine disrupters and affected aspects of growth and development
An EDC was defined by the US Environmental Protection Agency (EPA) as 'an exogenous agent that interferes with synthesis, secretion, transport, metabolism, binding, action, or elimination of natural blood-borne hormones that are present in the body and are responsible for homeostasis, reproduction, and developmental process'.
Examples of EDCs are given in Table 1 . As has been shown in the recent Third National Report by the Center for Disease Control [3] , humans are exposed to hundreds of environmental chemicals, of which dozens are known as EDCs.
Some aspects of development that can be disrupted by EDCs are listed in Table 2 together with the phenotypic disturbances resulting from those effects, the endocrine systems affected and some examples of EDCs possibly involved. Direct brain effects on cortex and hippocampus can occur through disruption of thyroid hormone action [e.g. polychlorinated biphenyls (PCBs), bisphenol A (BPA)] with consequences on cognitive abilities. The brain is also involved in some central nervous system (CNS) aspects of sexual differentiation and the hypothalamic control of reproduction and energy balance. In the present review, we will focus on developmental aspects leading to the control of reproduction and energy balance and we will put emphasis on the interactions between both systems. We will not discuss the psychomotor development issues, which are obviously crucial but involve different pathogenetic mechanisms with thyroid hormones as key mediators.
Limits in unravelling endocrine disrupter effects
It is challenging to link exposure to particular EDCs and health issues for several reasons [2 ] summarized in Table 3 . Humans as well as animals are likely exposed to a variety of EDCs acting as mixtures with time-related changes in compounds and doses. Mixtures result in more than additive effects, since compounds mixed at concentrations that were inactive when used as single EDCs have been shown to become active when used as mixtures [4] . The study of mixtures, however, is complex and laborious. So far the vast majority of studies have been performed with single classes of EDCs only. When exposure is assessed at the time of pubertal or adult disorders, there has been a very long period since fetal/ perinatal life, the most critical time for EDC effects. Sexual dimorphism is indeed a critical issue when EDC effects are considered. As a whole, EDCs appear to work either as estrogen agonists or as androgen antagonists with the ratio estrogen/androgen actions as an ultimate determinant of EDC effects [5] . Consistent with this concept is the observation that premature breast development can occur after exposure to phthalates, which are considered to act primarily as androgen antagonists [6] . Moreover, an estrogenic compound such as DDT can generate the antiandrogenic sub-product dichlorodiphenylchloroethene (DDE), which can also indirectly reflect previous exposure to DDT, further complicating the elucidation of estrogenic versus antiandrogenic effects [7] . Since both the reproductive and energy balance systems are regulated by feedback loops between peripheral tissues on the one hand and pituitary gland, hypothalamus and CNS on the other hand, EDCs can have an effect at any of those sites directly or secondarily through changes in hypothalamic-pituitary messengers or altered peripheral feedback. At a given cellular level, the mechanisms are complex, exerting both genomic and nongenomic effects on various types of receptors. These effects can be related to dose in a nonlinear manner (e.g. biphasic, U-shaped) as well [2 ] .
Critical developmental windows of endocrine disruption
As already pointed out, the DES story provided evidence that prenatal life was critical for occurrence of cancer in the offspring exposed to that EDC two to three decades earlier effects of sex steroids [9 ] as well as nutrition [10] on the homeostasis of reproduction and energy balance throughout subsequent life. Thus, the concept was extended as 'developmental origin of adult health and disease'. Convincing data on the programming effects of sex steroids arose from prenatal exposure of the ovine fetus to testosterone, which caused alteration of pubertal timing and estrus cyclicity through neuroendocrine alteration of estradiol positive feedback [11] . In similar conditions, fetal lamb exposure to the EDCs methoxychlor or BPA accounted for delayed or severely reduced luteinizing hormone (LH) surge, respectively, without change in pubertal timing [12] . The exposed animals also had ovarian anomalies, growth retardation and metabolic disorders that could contribute to disrupted reproductive function. Such an association of disorders could be related to the polycystic ovary syndrome (PCOS). This human condition was found to be integrated within a spectrum of anomalies (premature pubarche and metabolic syndrome) that are predicted by intrauterine growth retardation (IUGR) [13] . Another human condition consistent with early developmental EDC effects is the 'testicular dysgenesis syndrome' or TDS, an association of hypospadias, cryptorchidism, oligospermia and germ cell cancer that was proposed to result from disruption of embryonic/fetal programming and gonadal development [14] . In support of that hypothesis, Fisher et al. [15] reported a TDS-like condition after fetal rat exposure to phthalates.
Epigenetics and transgenerational endocrine disruption
Epigenetics refers to changes in gene chemical characteristics (methylation, acetylation) that affect gene expression without alterations in gene composition. This mechanism appears to be critical for enduring and sexspecific responses to environmental experiences during early life depending on variations in maternal diet or sex steroids, for instance [9 ] . Therefore, involvement of epigenetics in the mechanism of EDC effects could be anticipated. Of the utmost importance is the finding that transient exposure of fetal rodents to EDCs (vinclozolin, methoxychlor) at the time of germ cell line differentiation results in effects, including alterations of DNA methylation and fertility impairment, that are transferred to several subsequent generations [16] . Further, transgenerational effects were shown to involve energy balance and other aspects of reproduction, including behavior. In a study performed three generations after the progenitors were exposed to vinclozolin, female rodents preferred males with no history of exposure for mating [17] . These findings might suggest epigenetic changes in the neuroendocrine components of sexual behavior regulation. Direct evidence of epigenetic mechanisms in the hypothalamus in relation to sexual differentiation has been obtained recently [18] , as well as effects on methylation pattern of the promoter of estrogen receptor beta gene in the adult ovary [19] . Recently, hypermethylation was found to explain why a homeobox gene controlling uterine organogenesis showed altered expression after fetal exposure to DES [20] . Overall, those findings emphasize again the critical role of prenatal and early postnatal life. The transgenerational effects and epigenetic mechanisms deserve further studies in different species and, if possible, epidemiological investigations in clinical conditions that could match some of the experimental observations.
Clinical and experimental evidence suggestive of endocrine disruption of growth and development
In order to confirm the reality of endocrine disruption, it can be helpful to assess the effects of given EDCs in a developmental perspective and through comparison of human and animal data. This is the purpose of Table 4 for four EDCs. Quite clearly, neonatal period and adulthood are the times when most effects of EDCs are reported, whereas few observations have been made so far during growth and development, that is in infancy, childhood and adolescence [2 ]. It appears from Table 4 that humans and laboratory animals share common disturbances after exposure to DES, DDT and phthalates. In addition, these three EDCs account for anomalies of sex differentiation, though DES and DDT are primarily Classical endocrine receptors as well as nonclassical endocrine or nonendocrine receptors can be involved in addition to alterations in the rates of degradation of endogenous hormones and EDCs estrogen agonists, whereas phthalates are antiandrogenic. So far, human evidence of BPA effects is limited. Finally, the reproductive system is most obviously affected by EDCs, though evidence is emerging that aspects of energy balance are involved as well.
Puberty warrants some discussion in relation to EDCs since it is a crucial event in growth and development together with achievement of reproductive capacity. Around the year 2000, two large American studies provided evidence of earlier onset of puberty [21, 22] . Very recently relatively similar findings were obtained in Denmark and Belgium [23 ,24] . In all four studies, it appeared that onset of breast development was more affected than menarcheal age. Because those changes in pubertal timing were concomitant with the epidemic of obesity in the USA, the pathophysiological involvement of fat mass, possibly through leptin [21, 22, 25] , was hypothesized in that country. However, the recent changes in pubertal timing in Denmark were not associated with changes in adiposity [23 ] . Thus other factors, including EDCs, could be involved [26] . We and others reviewed recently association between exposure to EDCs and variations in pubertal timing [27, 28, 29 ]. In girls, DDE and DDT as well as PCBs and polybrominated biphenyls tended to be associated with early timing, whereas late timing could be observed after exposure to dioxins. Phytoestrogens did not show any effect. In boys, PCBs could also account for some pubertal delay. In a very recent American study of urinary biomarkers of EDCs in a cohort of 1151 girls aged 6-8 years, it was concluded that there was a weak positive association of urinary phthalates with timing of breast development [30] . This observation may have been limited by the studied EDCs and, more importantly, a time factor if pubertal timing is dependent on exposure to EDCs in fetal and early postnatal life.
Additional evidence of possible environmental effects on pubertal timing in humans came from studies in children migrating for international adoption. As cohorts, they appeared to mature earlier than children in the foster countries and in the countries of origin [31] . Also, sexual precocity requiring gonadotropin releasing hormone (GnRH) agonist therapy was much more common in those migrating children than in others [32, 33] . On the basis of increased serum levels of DDE, a derivative of the estrogenic insecticide DDT found among migrating children, we hypothesized that early exposure to this EDC and subsequent withdrawal due to migration could account for a neuroendocrine pathogenetic mechanism of secondary central precocious puberty [31, 32] . This hypothesis was substantiated in a rat model [7, 34] . The mechanistic interpretation is that, during exposure to DDT, estrogenic effects account for both peripheral and central (neuroendocrine) stimulation. However, due to concomitant negative feedback inhibition at the pituitary level, the central effects are not translated into gonadotropin stimulation of the ovaries until the pituitary inhibition disappears following migration into a DDT-free environment.
In a study of internationally adopted girls aged 5-8 years and still clinically prepubertal, Teilmann and co-workers [35] reported that serum follicle stimulating hormone and estradiol levels were already elevated in several girls, confirming early pituitary-ovarian activity after migration. The above mechanism is comparable to that operating in other conditions with peripheral precocious puberty (e.g. congenital adrenal hyperplasia, adrenal or gonadal tumors) followed by secondary central precocious puberty after the peripheral disorder is cured by medical or surgical treatment [31] . However, the very long half-life of the DDT derivative DDE could have biased the study. Many other EDCs with shorter half-lives, and thus undetectable at the time of sexual precocity diagnosis, could have been involved as well. Moreover, it is likely that other factors, including recovery from earlier nutritional as well as psychosocial deprivation, could play some role in this particular condition [36] .
Endocrine disruption of growth and development: a common early homeostatic disturbance?
The neuroendocrine system in the hypothalamus is a common place for regulation of different aspects of homeostasis, including reproduction and energy balance. It is also involved, during fetal and neonatal life, in programming mechanisms accounting for the 'developmental origin of health and diseases' [10] . Peripheral messengers from the gonads (e.g. sex steroids) and from adipose tissue (e.g. leptin, adiponectin) can also play important regulatory roles in linking energy balance and reproduction throughout life. In Fig. 1 are integrated some of the many connections between homeostasis of reproduction and homeostasis of energy balance, centrally and peripherally, during both prenatal/neonatal and postnatal life [29 ] .
Feto-maternal malnourishment or overfeeding with fat, as well as fetal exposure to sex steroids or endocrine disrupters such as DES and BPA, were shown to possibly result in low birth weight, early puberty, ovulatory disorders, obesity in adulthood and metabolic syndrome [10, 37 ,38,39 ] . Both sex steroids and leptin are involved in early organizational effects in the hypothalamus that affect respectively the central control of reproduction [40 ] and energy balance [41 ] . Peripherally, whereas EDC effects on male and female reproductive tract have been extensively described [2 ] , EDCs appeared more recently to cause induction of cell differentiation and adipogenesis [42] as well as lipid accumulation in differentiated adipocytes [43] . Gestational and lactational exposure to BPA resulted in increased adipogenesis at weaning in female rats [44] . Adiponectin, a factor protecting against obesity and insulin resistance, could play a role as well. Using mature abdominal adipocytes in vitro, BPA reduced the secretion of several adipokines including adiponectin [45, 46] . It was suggested recently that obesity and metabolic syndrome could involve primary peripheral mechanisms through early impact of nutrition on increased adipogenic and lipogenic capacity of adipocytes [47 ] . The hypothesis was also raised that EDC effects on adipose tissue and energy balance could provide the basis of a toxicological mechanism in the obesity epidemic [39 ,48] . Since soy-derived products are widely used in infancy, data obtained with phytoestrogens deserve special attention. Adiposity is reduced and insulin sensitivity increased in mice fed from conception to adulthood with a phytoestrogen-rich diet [49] . AgRP, Agouti-related protein; Dis. Sex differ., disorders of sex differentiation; EDCs, endocrine disrupting compounds.
There are several lines of experimental and clinical evidence of cross-talk between the systems controlling reproduction on the one hand and energy balance on the other hand. Experimentally, reduced serum leptin levels are observed neonatally in association with reduced anogenital distance after fetal exposure to phthalates [50] . During postnatal life, leptin is an important link between energy balance and reproduction through facilitatory effects on GnRH secretion [31, 51] . Through inhibition of adiponectin release, EDC could facilitate GnRH secretion, since immortalized GnRH neurons were shown to express adiponectin receptors and GnRH release was reduced in the presence of adiponectin [52] . Clinically, cross-talk is supported by the recent finding that fast weight gain in infancy between birth and 9 months predicts increased adiposity at 10 years and early menarcheal age [53] . Ibáñ ez et al. [13] reported that IUGR was associated with increased risk of premature pubarche, hyperinsulinism, ovarian hyperandrogenism and PCOS. These findings can be correlated with several experimental effects of manipulation of nutrition or exposure to sex steroids or EDCs in the fetus as detailed above. Of particular interest is the observation that IUGR is associated with increased visceral adiposity and reduced serum levels of adiponectin in childhood [54] . The latter effect parallels BPA-induced reduction of adiponectin production by adipocytes [45, 46] . All together, those findings indicate that both the human reproductive system and energy balance system share a possible fetal/early postnatal determinism of adult disorders under the influence of early nutritional conditions and/or early exposure to EDCs, with mechanistic crosstalk between the two systems.
Conclusion and recommendations for the pediatrician
Due to ubiquity and multiplicity of EDCs, their environmental impact on health becomes an increasing matter of concern. Fetal and early postnatal periods are most critical for adverse health consequences, most of which, however, are expressed phenotypically only after several decades in humans. Additional concern arises from epigenetics, which possibly accounts for heritability of altered gene expression after exposure to EDCs. While research efforts are pursued to further delineate the consequences of exposure to EDCs in humans and wildlife, the precautionary principle should be followed. The ban on polycarbonate baby bottles by Canadian authorities in 2008 and the recent FDA statement about BPA exposure of very young children [55] are consistent with that principle. Recommendations for the pediatrician taking care of young children are proposed in Table 5 . They are relevant as well for gynecologists taking care of pregnant women, and they require continuing adjustment based on new findings from clinical and experimental research. 
